SCHEMBL23713498

SCHEMBL23713498

CCOc1ccc2cc(-c3ccc(OC(F)(F)F)cc3)c(=O)oc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.56
NPC1 O15118 8/20 0.56
POLB P06746 2/20 0.55
GLA P06280 4/20 0.54
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 3/20 0.54
GAA P10253 2/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
RECQL P46063 1/20 0.54
STS P08842 1/20 0.53
PTPN7 P35236 1/20 0.53
MAOB P27338 1/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CYP1A2 P05177 1/20 0.51
CA4 P22748 1/20 0.51
CA6 P23280 1/20 0.51
CA5A P35218 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24046224 0.86 NPC1 (0.70) RAB9ANPC1STSMAOBCA1
SCHEMBL7123290 0.85 NPC1 (0.74) RAB9ANPC1POLBGLAALDH1A1
SCHEMBL7114353 0.84 MIF (0.60) RAB9ANPC1POLBGLAALDH1A1
SCHEMBL18535597 0.83 MAOB (0.62) RAB9ANPC1POLBGLAALDH1A1
SCHEMBL23713535 0.83 RAB9A (0.51) RAB9ANPC1POLBGLAALDH1A1
SCHEMBL18583392 0.82 NPC1 (0.72) RAB9ANPC1POLBGLAALDH1A1
SCHEMBL18583385 0.82 NPC1 (0.55) RAB9ANPC1POLBGLAALDH1A1
SCHEMBL24046257 0.81 STS (0.51) RAB9ANPC1POLBGLAALDH1A1
SCHEMBL18583703 0.81 MIF (0.70) RAB9ANPC1POLBGLAALDH1A1
SCHEMBL22625376 0.81 RXFP1 (0.59) RAB9ANPC1POLBGLAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078177-B2 Compounds for optically active devices MERCK PATENT GMBH (DE) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078177-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A RAB9A 930/4885NPC1 2482/4885POLB 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.